LB Pharmaceuticals Inc Common Stock

NASDAQ:LBRX

Biotechnology

Healthcare
$40.06 -1.30%

-$0.39 today

Market cap
$1.30B
Beta
0.71
P/E (TTM)
-21.4
EPS (TTM)
-$1.39
52W Low $13.36High $33.47

Volume 0.36M

Average 0.23M

Price history

LB Pharmaceuticals Inc Common Stock SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+151.63%

Period high

$49.48

Period low

$15.33

Latest

$40.06

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 5, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
4Oct 13, 2026Oct 13, 2026
4Oct 13, 2026Oct 13, 2026
SC 13G/AOct 13, 2026Oct 13, 2026
EFFECTOct 5, 2026Oct 6, 2026
POS AMOct 1, 2026Oct 1, 2026
S-3ASROct 1, 2026Oct 1, 2026
3Sep 24, 2026Sep 24, 2026
424B3Sep 15, 2026Sep 15, 2026
8-KSep 15, 2026Sep 15, 2026
3Sep 14, 2026Sep 14, 2026
424B3Sep 3, 2026Sep 3, 2026
8-KSep 3, 2026Sep 3, 2026
SC 13G/AAug 14, 2026Aug 14, 2026

Competitors

Who does LB Pharmaceuticals Inc Common Stock compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about LBRX's filings, answered from its disclosures.

What is the latest LBRX filing?

The latest filing shown is 10-Q dated Nov 5, 2026.

How many recent filings does LBRX have?

Intrinsic Alpha currently shows 20 recent filings for LBRX.